Afuco™ Anti-Human CSF1 ADCC Theraputic Antibody (PD-0360324), ADCC Enhanced
Product Quick Detail
- Minimum Order
- 1
- Place Of Origin
- USA
- Packaging
- N/A
- Delivery
- 15 Days
Specifications
Anti-CSF1 ADCC Enhanced Antibody (PD-0360324) is an ADCC enhanced antibody produced by our Afuco™ platform. This is a novel neutralizing human monoclonal antibody against monocyte/ macrophage
colony stimulating factor (M-CSF). It exhibited a nonlinear PK profile associated with rapid suppression of PD markers and was generally well tolerated. The safety and efficacy profile will be
investigated further in a multi-dose study in patients with rheumatoid arthritis.
https://www.creativebiolabs.net/Anti-CSF1-ADCC-Enhanced-Antibody-PD-0360324-20483.htm
- Country: United States
- Business Type:
- Market:
- Founded Year:2005
- Address:
- Contact:Jerry Carter
